QCG
ARIA

Quadrant Capital Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Quadrant Capital Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-889
Closed -$11K – 2213
2016
Q4 		$11K Hold
889
– – 0.01% 1007
2016
Q3 		$12K Hold
889
– – 0.01% 997
2016
Q2 		$6K Hold
889
– – ﹤0.01% 1202
2016
Q1 		$5K Buy
+889
New +$4.98K ﹤0.01% 1201

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Quadrant Capital Group's ARIA Position: Q1 2017 in Review

Quadrant Capital Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 889 shares — an estimated $11K sold.

Quadrant Capital Group first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $12K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Quadrant Capital Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Quadrant Capital Group sold 889 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $11K.
  • Quadrant Capital Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
  • Quadrant Capital Group's Ariad Pharmaceuticals Inc position peaked at $12K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.